Comparing the PiCCO Monitor to the Non-invasive Biobeat (BB)-316PW in ICU Patients

Biobeat Technologies Ltd.9 enrolled

Overview

The aim of this study is to compare hemodynamic monitoring using the invasive PiCCO device to the BB-613PW wireless, non-invasive PPG-based device, in critically ill patients within the ICU, suffering from hemodynamic instability and in need of vasopressor support. Data will be gathered prospectively and analysed retrospectively.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Critically Ill Hemodynamic Instability

Interventions

non-invasive monitoringDEVICE

Comparing the PiCCO monitor to the non-invasive BB-613PW device in hemodynamically unstable critically ill patients in the ICU

Eligibility

Sex: ALLMin age: 18 YearsMax age: 99 Years

Medical Language ↔ Plain English

Inclusion Criteria: * ICU adult patients in the need of vasopressor support of more than 0.2 mcg/Kg/Min for a period longer than 3 hours * Patients in which PiCCO monitoring is needed Exclusion Criteria: * Refusal of the subject * Technical difficulties in insertion of the PiCCO catheters * Significant cardiac arrhythmias * Significant valvular disease * Pregnancy

Locations (1)

The Assaf Harofeh Medical Center, Zrifin

Rishon LeZiyyon, Israel

Outcomes

Primary Outcomes

Level of accordance between the BB-613PW to the PiCCO

We will compare the level of accordance of blood pressure, heart rate, stroke volume, cardiac output, heart rate variability, and systemic vascular resistance.

Time frame: 72 hours per individual

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.